These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 20933445

  • 1. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
    Fritsche HM, Novara G, Burger M, Gupta A, Matsumoto K, Kassouf W, Sircar K, Zattoni F, Walton T, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Otto W, Wieland WF, Karakiewicz PI, Ficarra V, Hartmann A, Shariat SF.
    Urol Oncol; 2012 Sep; 30(5):666-72. PubMed ID: 20933445
    [Abstract] [Full Text] [Related]

  • 2. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Martínez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V.
    Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B, Djokic M, Sipetic-Grujicic S, Grozdic Milojevic I, Vuksanovic A, Nikic P, Vukovic I, Djordjevic D, Bumbasirevic U, Tulic C.
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [Abstract] [Full Text] [Related]

  • 4. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients.
    Remzi M, Haitel A, Margulis V, Karakiewicz P, Montorsi F, Kikuchi E, Zigeuner R, Weizer A, Bolenz C, Bensalah K, Suardi N, Raman JD, Lotan Y, Waldert M, Ng CK, Fernández M, Koppie TM, Ströbel P, Kabbani W, Murai M, Langner C, Roscigno M, Wheat J, Guo CC, Wood CG, Shariat SF.
    BJU Int; 2009 Feb; 103(3):307-11. PubMed ID: 18990163
    [Abstract] [Full Text] [Related]

  • 5. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
    Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD, Wood CG, Upper Tract Urothelial Carcinoma CollaborationThe Upper Tract Urothelial Carcinoma Collaboration.
    Cancer; 2009 Mar 15; 115(6):1224-33. PubMed ID: 19156917
    [Abstract] [Full Text] [Related]

  • 6. Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Rink M, Sharifi N, Fritsche HM, Aziz A, Miller F, Kluth LA, Ngamsri T, Dahlem R, Chun FK, Shariat SF, Stenzl A, Fisch M, Gakis G.
    J Urol; 2014 Feb 15; 191(2):316-22. PubMed ID: 24036235
    [Abstract] [Full Text] [Related]

  • 7. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
    Godfrey MS, Badalato GM, Hruby GW, Razmjoo M, McKiernan JM.
    BJU Int; 2012 Sep 15; 110(6):798-803. PubMed ID: 22313599
    [Abstract] [Full Text] [Related]

  • 8. Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study.
    Seitz C, Gupta A, Shariat SF, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Otto W, Tritschler S, Bastian PJ, Carballido J, Ficarra V, Karakiewicz PI, Artibani W, Mazzoleni G, Novara G.
    J Urol; 2010 Nov 15; 184(5):1895-900. PubMed ID: 20846680
    [Abstract] [Full Text] [Related]

  • 9. Urothelial carcinoma at the uretero-enteric junction: multi-center evaluation of oncologic outcomes after radical nephroureterectomy.
    Youssef RF, Shariat SF, Lotan Y, Cost N, Wood CG, Sagalowsky AI, Zigeuner R, Langner C, Chromecki TF, Montorsi F, Bolenz C, Margulis V.
    Urol Oncol; 2013 Jul 15; 31(5):676-81. PubMed ID: 21704538
    [Abstract] [Full Text] [Related]

  • 10. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.
    Chromecki TF, Cha EK, Fajkovic H, Margulis V, Novara G, Scherr DS, Lotan Y, Raman JD, Kassouf W, Bensalah K, Weizer A, Kikuchi E, Roscigno M, Remzi M, Matsumoto K, Walton TJ, Pycha A, Ficarra V, Karakiewicz PI, Zigeuner R, Pummer K, Shariat SF.
    Eur Urol; 2012 Feb 15; 61(2):245-53. PubMed ID: 21975249
    [Abstract] [Full Text] [Related]

  • 11. Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma.
    Bagrodia A, Kuehhas FE, Gayed BA, Wood CG, Raman JD, Kapur P, Derweesh IH, Bensalah K, Sagalowsky AI, Shariat SF, Lotan Y, Margulis V.
    Urology; 2013 May 15; 81(5):972-7. PubMed ID: 23523292
    [Abstract] [Full Text] [Related]

  • 12. Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy.
    Gakis G, Fritsche HM, Hassan F, Kluth L, Miller F, Soave A, Otto W, Schwentner C, Todenhöfer T, Dahlem R, Burger M, Fisch M, Stenzl A, Aziz A, Rink M.
    Eur J Cancer; 2014 Oct 15; 50(15):2583-91. PubMed ID: 25088206
    [Abstract] [Full Text] [Related]

  • 13. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Obata J, Kikuchi E, Tanaka N, Matsumoto K, Hayakawa N, Ide H, Miyajima A, Nakagawa K, Oya M.
    Urol Oncol; 2013 Nov 15; 31(8):1725-30. PubMed ID: 23141922
    [Abstract] [Full Text] [Related]

  • 14. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
    Colin P, Ouzzane A, Pignot G, Ravier E, Crouzet S, Ariane MM, Audouin M, Neuzillet Y, Albouy B, Hurel S, Saint F, Guillotreau J, Guy L, Bigot P, De La Taille A, Arroua F, Marchand C, Matte A, Fais PO, Rouprêt M, French Collaborative National Database on U.U.T.-U.C.
    BJU Int; 2012 Oct 15; 110(8):1134-41. PubMed ID: 22394612
    [Abstract] [Full Text] [Related]

  • 15. Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection.
    Espiritu PN, Sverrisson EF, Sexton WJ, Pow-Sang JM, Poch MA, Dhillon J, Spiess PE.
    Urol Oncol; 2014 Jul 15; 32(5):619-24. PubMed ID: 24495448
    [Abstract] [Full Text] [Related]

  • 16. Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.
    Vartolomei MD, Mathieu R, Margulis V, Karam JA, Rouprêt M, Lucca I, Mbeutcha A, Seitz C, Karakiewicz PI, Fajkovic H, Wood CG, Weizer AZ, Raman JD, Rioux-Leclercq N, Haitel A, Bensalah K, Rink M, Briganti A, Xylinas E, Shariat SF.
    World J Urol; 2017 Jan 15; 35(1):121-130. PubMed ID: 27209168
    [Abstract] [Full Text] [Related]

  • 17. Radical nephroureterectomy for pathologic T4 upper tract urothelial cancer: can oncologic outcomes be improved with multimodality therapy?
    Youssef RF, Lotan Y, Sagalowsky AI, Shariat SF, Wood CG, Raman JD, Langner C, Zigeuner R, Roscigno M, Montorsi F, Bolenz C, Kassouf W, Margulis V.
    Int Braz J Urol; 2013 Jan 15; 39(5):614-21. PubMed ID: 24267122
    [Abstract] [Full Text] [Related]

  • 18. A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Tanaka N, Kikuchi E, Kanao K, Matsumoto K, Shirotake S, Miyazaki Y, Kobayashi H, Kaneko G, Hagiwara M, Ide H, Obata J, Hoshino K, Hayakawa N, Kosaka T, Hara S, Oyama M, Momma T, Nakajima Y, Jinzaki M, Oya M.
    Ann Surg Oncol; 2014 Nov 15; 21(12):4041-8. PubMed ID: 24912614
    [Abstract] [Full Text] [Related]

  • 19. Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study.
    Martinez-Salamanca JI, Shariat SF, Rodriguez JC, Chromecki TF, Ficarra V, Fritsche HM, Kassouf W, Matsumoto K, Cabello LO, Seitz C, Tritschler S, Walton TJ, Zattoni F, Novara G.
    BJU Int; 2012 Apr 15; 109(8):1155-61. PubMed ID: 21883847
    [Abstract] [Full Text] [Related]

  • 20. Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: results of a current series and a review of the literature.
    Krabbe LM, Westerman ME, Bagrodia A, Gayed BA, Khalil D, Kapur P, Shariat SF, Raj GV, Sagalowsky AI, Cadeddu JA, Lotan Y, Margulis V.
    Urol Oncol; 2014 Jan 15; 32(1):54.e19-26. PubMed ID: 24360665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.